Rethinking Cancer Treatment: Earli Featured in Nikkei Japan
By SHARON SIM • December 5, 2025

Nikkei Japan, with 1.5M circulation, recently featured Silicon Valley-based Earli’s CEO and co-founder, Cyriac Roeding, in an op-ed exploring the need to shift from traditional early cancer detection and treatment methods based on often undruggable or completely missing natural cancer biomarkers to a new, engineering-led approach to cancer treatment.
The article outlines how Earli’s technology proposes a paradigm shift—bioengineering cancer cells to produce their own markers and trigger immune responses, opening a path to control cancer more effectively rather than chasing it. SKC is proud to help amplify this important message. Read the full article in Nikkei Japan.
Insights to fuel your marketing business
Sign up to get industry insights, trends, and more in your inbox.
Contact Us
We will get back to you as soon as possible.
Please try again later.
SHARE THIS
Latest Blogs









